The medical technology company Polarcool has received final approval under MDSAP after the completion of Stage 1 and Stage 2 audits conducted by Intertek. This enables the company to proceed with the application for product approval for Polarcap in Canada. The MDSAP certification means that the company's quality system is approved for several markets outside Europe, including Canada, USA and Australia. The next step is product approvals from Health Canada and FDA, with the goal of receiving the green light in the first half of 2026.